-
Study aim
-
The evaluation of adding tecar therapy effect on routine physiotherapy treatments compared to placebo tecar and routine physiotherapy treatments on pain, disability and electrical activity of erector spine muscles in patients with non-specific chronic low back pain
-
Design
-
Clinical trial with a control group, with parallel groups, three blinded, randomized, on 32 patients. The rand function of Excel software was used for randomization.
-
Settings and conduct
-
In this study, 32 patients with non-specific chronic back pain are divided into two groups of 16, treatment and control. In the treatment group, 20 minutes of Tecar therapy, 35 minutes of routine physiotherapy (20 minutes of TENS and 15 minutes of IR and exercise therapy) and the control group (placeboTecar and routine physiotherapy) are performed.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Patients with back pain who do not have documentation of discopathy or disc herniation
Patients with symptoms of chronic back pain who are between 20 and 60 years old
Diagnosis of chronic back pain for at least 12 weeks
Visual pain index 4-7
Exclusion criteria:
Contraindication of tecar therapy: neoplasm, regional infection, patients with cardiac pacemaker and pregnancy.
Active vertebral fracture
previous spine surgery
Rheumatoid diseases such as rheumatoid arthritis
infectious diseases
Systemic diseases that affect pain perception, such as diabetes and...
Local injection such as (local anesthesia, corticosteroid...)
Taking medicines and doing physiotherapy in the last 4 weeks
-
Intervention groups
-
The intervention group includes Tecar therapy, routine physiotherapy (IR, TENS and exercise therapy). The control group is the same as the intervention group, but Tecar will be done as placebo.
-
Main outcome variables
-
VAS scale
Oswestry disability scale
electrical activity of the paraspinal muscles